NNovo Nordisk Read More Novo Nordisk A/S – share repurchase programme2026-08-17 Bagsværd, Denmark, 17 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in…
NNovo Nordisk Read More Novo Nordisk A/S – share repurchase programme2026-08-10 Bagsværd, Denmark, 10 August 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in accordance…
NNovo Nordisk Read More Novo Nordisk’s Defining Moment: Can a Pill Outweigh a Pipeline Setback?2026-08-04 The arithmetic of Novo Nordisk’s share price has become uncomfortably simple. At Monday’s close of 40.83 euros, the…
NNovo Nordisk Read More Novo Nordisk Faces a Legal Double Header as Earnings Approach2026-07-30 The Danish pharmaceutical heavyweight is fighting on two legal fronts just days before a pivotal earnings report, with…
NNovo Nordisk Read More Novo Nordisk: A Stock Caught Between Courtroom Battles and a Deep Value Gap2026-07-29 Novo Nordisk’s shares have staged a remarkable recovery from their March lows, yet the Danish pharmaceutical giant remains…
NNovo Nordisk Read More Novo Nordisk A/S – share repurchase programme2026-07-27 Bagsværd, Denmark, 27 July 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase programme in…
NNovo Nordisk Read More Novo Nordisk Deploys Licensed Semaglutide Copy in South Africa While Waging Legal War on Two Fronts2026-07-27 The Danish drugmaker is fighting for its GLP-1 franchise on multiple fronts — from the courtroom to the…
NNovo Nordisk Read More Novo Nordisk Faces a Two-Pronged Test: Quarterly Results and a Pivotal FDA Decision2026-07-26 The Danish pharmaceutical giant Novo Nordisk enters a defining stretch this week, with its second-quarter earnings due on…
NNovo Nordisk Read More Novo Nordisk Takes Lilly to Court Over GLP-1 Ad Claims as Market Share Battle Intensifies2026-07-26 Novo Nordisk has escalated its legal confrontation with Eli Lilly, filing for a preliminary injunction in a New…
NNovo Nordisk Read More Novo Nordisk Faces a Double Squeeze: Lilly’s Record-Breaking Data and a High-Stakes Court Date2026-07-25 Eli Lilly has thrown down a fresh gauntlet in the GLP-1 arms race, unveiling late-stage data that shows…
NNovo Nordisk Read More Novo Nordisk Shares Climb on Dual Tailwinds, but Data Gaps and Cost Concerns Keep Bulls in Check2026-07-20 Novo Nordisk’s stock has clawed back ground from its March lows, powered by two distinct catalysts: a newly…
NNovo Nordisk Read More Novo Nordisk Gets Hemophilia Boost as CagriSema Device Pause Stays in the Background2026-07-14 Novo Nordisk shares are staging a recovery from March’s 52-week trough, supported by encouraging late-stage hemophilia data and…